| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $411K | — | +301.2% |
| R&D Expense | $209K | — | -65.6% |
| SG&A Expense | $4.6M | — | +329.7% |
| Operating Income | -$5.1M | — | -383.8% |
| Interest Expense | $99K | — | +0.0% |
| Pre-tax Income | -$5.2M | — | -406.5% |
| Net Income | -$5.2M | — | -406.5% |
| EPS (Basic) | -$0.13 | — | -85.7% |
| EPS (Diluted) | -$0.13 | — | -85.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.2M | +250.7% | — |
| Accounts Receivable | $86K | +51.9% | +139.5% |
| Current Assets | $16.7M | +212.1% | +185.7% |
| Total Assets | $45.6M | +43.2% | +536.8% |
| Current Liabilities | $10.1M | +58.0% | — |
| Long-term Debt | $6.8M | -33.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | -186.7% |
| Capital Expenditures | $1.7M | — | — |
| Investing Cash Flow | -$1.8M | — | -1003.2% |
| Financing Cash Flow | $17.1M | — | +346.6% |
| Free Cash Flow | -$5.4M | — | — |
| — |
| Total Liabilities | $10.3M | -19.9% | +6429.5% |
| Stockholders' Equity | $35.3M | +85.9% | +404.3% |